<DOC>
	<DOCNO>NCT01929148</DOCNO>
	<brief_summary>We already demonstrate addiction PBS Total Laparoscopic Hysterectomy ( TLH ) negative effect term ovarian function , evaluate anti-Müllerian hormone ( AMH ) , Follicle Stimulating Hormone ( FSH ) , Antral Follicle Count ( AFC ) , mean ovarian diameter Peak Systolic Velocity ( PSV ) . In addition , experience , negative surgical outcome ( term operative time , intraoperative blood loss , postoperative hospital stay , postoperative return normal activity complication rate ) relate PBS step TLH . Although good statistical reliability retrospective data , want prospectively confirm result . Moreover aim refine PBS safety demonstration collect also 3D ultrasound parameter [ AFC , ovarian volume ( OV ) , Vascularization Index ( VI ) , Flow Index ( FI ) Vascularization Flow Index ( VFI ) ] . Hormonal ultrasonographic parameter may possibly unify new diagnostic algorithm ( already advance stage production UMG Department ) able estimate ovarian function term reproductive ability term distance menopause .</brief_summary>
	<brief_title>Prophylactic Bilateral Salpingectomy Laparoscopic Myomectomy</brief_title>
	<detailed_description>We enroll first 77 patient agree implement PBS laparoscopic myomectomy ( LM ) ( study group ) , start September 1 , 2013 . Other 77 patient ask u undergo LM without addiction PBS constitute control group . For patient , ovarian reserve modification surgery record primary outcome . Specifically , one month three month laparoscopy , day 1 4 menstrual cycle serum AMH , FSH E2 evaluate transvaginal ultrasound examination ( Voluson E8 Expert Voluson-i - GE Healthcare Ultrasound ) ass AFC , OV , VI , FI VFI , carry experienced ultrasonographist responsible ambulatory ovarian reserve Unit . Ovarian reserve modification define difference ( express Δ ) post-operative pre-operative value AMH , FSH , AFC , OV , VI , FI VFI . For surgical procedure , moreover , operative time , variation hemoglobin level , postoperative hospital stay , postoperative return normal activity complication rate record secondary outcome .</detailed_description>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>Indication laparoscopic myomectomy Accomplished reproductive desire Age old 50 year family history ovarian cancer , BRCA positive basal FSH value &gt; 20 IU/mL and/or E2 level &gt; 60 pg/mL presence menopausal symptom , irregular ( cycletocycle variation 12 month &gt; 20 day orpresence breakthrough bleed ) menstrual cycle , hormonereplacement treatment and/or hormonal contraception last 3 month , history previous uterine ovarian surgery , image suggestive ovarian cyst tubal pathology transvaginal ultrasound .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>risk-reducing salpingectomy</keyword>
	<keyword>prophylactic bilateral salpingectomy</keyword>
	<keyword>ovarian cancer prevention</keyword>
	<keyword>ovarian reserve</keyword>
</DOC>